InvestorsHub Logo
Followers 47
Posts 6374
Boards Moderated 0
Alias Born 06/17/2009

Re: TempePhil post# 297189

Saturday, 02/06/2021 9:56:33 PM

Saturday, February 06, 2021 9:56:33 PM

Post# of 471267
Phil, I'm thinking, pre-AD, that the evidence of 2-73's benefits is going to be convincing for the authorities with efficacy in AD, Rett and PDD, but possibly not in the individual numbers for each disease that Anavex and the FDA-types arrive at an agreement that allows for the commercialization of 2-73, but with a P-4 to provide the long-term support for those decisions.

With the various analyses being done via PM/AI in three different diseases, approval in Australia, Europe and/or USA might not be as far off as some project. At least, that is my prayer for me and all those who are slipping into the AD hole as well as those already in the hole.


ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News